ECMO for Metabolic Crisis in a Patient with Mitochondrial Disease
Author(s) -
Sonal Sharma,
Clifford Deerman,
Michael H. Andreae,
Conrad S. Myler
Publication year - 2021
Publication title -
case reports in anesthesiology
Language(s) - English
Resource type - Journals
eISSN - 2090-6390
pISSN - 2090-6382
DOI - 10.1155/2021/9914311
Subject(s) - lactic acidosis , medicine , extracorporeal membrane oxygenation , decompensation , disease , metabolic acidosis , perforation , acidosis , mitochondrion , intensive care medicine , biochemistry , biology , materials science , punching , metallurgy
Patients with mitochondrial disease exhibit disrupted pyruvate oxidation, resulting in intraoperative and perioperative physiologic derangements. Increased enzymatic conversion of pyruvate via lactate dehydrogenase during periods of fasting or stress can lead to metabolic decompensation, with rapid development of fatal lactic acidosis. We describe the intraoperative management and postoperative critical care of a patient with mitochondrial disease who presented for repair of esophageal perforation following repair of a paraesophageal hernia. His surgery was complicated by the development of metabolic crisis and severe lactic acidosis which became resistant to conventional therapy before ultimately resolving with the initiation of venoarterial extracorporeal membrane oxygenation (VA-ECMO).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom